Cuproptosis-related LncRNAs signature as biomarker of prognosis and immune infiltration in pancreatic cancer

Cuproptosis-related LncRNAs signature as biomarker of prognosis and immune infiltration in pancreatic cancer

Background: Pancreatic cancer (PC) is a malignant gastrointestinal tumor with a terrible prognosis. Cuproptosis is a recently discovered form of cell death. This study is intended to explore the relationship between cuproptosis-related lncRNAs (CRLncs) signature with the prognosis and the tumor micr...

Full description

Bibliographic Details
Main Authors:	Hui Chen, Yang Yu, Lei Zhou, Junliang Chen, Zeyu Li, Xiaodong Tan
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-01-01
Series:	Frontiers in Genetics
Subjects:	pancreatic cancer cuproptosis lncRNA signature mutation landscape tumor microenvironment
Online Access:	https://www.frontiersin.org/articles/10.3389/fgene.2023.1049454/full

Similar Items

Cuproptosis-associated lncRNAs discern prognosis and immune microenvironment in sarcoma victims
by: Binxiang Chu, et al.
Published: (2022-12-01)

Prognostic analysis of hepatocellular carcinoma based on cuproptosis -associated lncRNAs
by: Mingwei Wei, et al.
Published: (2024-04-01)

A novel cuproptosis-related prognostic 2-lncRNAs signature in breast cancer
by: Qi-Tong Xu, et al.
Published: (2023-01-01)

Comprehensive analysis of cuproptosis-related lncRNAs signature to predict prognosis in bladder urothelial carcinoma
by: Shusheng Zhu, et al.
Published: (2023-07-01)

Comprehensive analysis of cuproptosis-related lncRNAs for prognostic significance and immune microenvironment characterization in hepatocellular carcinoma
by: Duguang Li, et al.
Published: (2023-01-01)

A novel defined risk signature of cuproptosis-related long non-coding RNA for predicting prognosis, immune infiltration, and immunotherapy response in lung adenocarcinoma
by: Chao Ma, et al.
Published: (2023-08-01)

A cuproptosis-related lncRNAs signature predicts prognosis and reveals pivotal interactions between immune cells in colon cancer
by: Jingru Song, et al.
Published: (2024-07-01)

Potential of lncRNAs to regulate cuproptosis in hepatocellular carcinoma: Establishment and validation of a novel risk model
by: Jing He, et al.
Published: (2024-01-01)

Developing four cuproptosis-related lncRNAs signature to predict prognosis and immune activity in ovarian cancer
by: Li Liu, et al.
Published: (2023-04-01)

Comprehensive analysis of a novel cuproptosis-related lncRNA signature associated with prognosis and tumor matrix features to predict immunotherapy in soft tissue carcinoma
by: Binfeng Liu, et al.
Published: (2022-12-01)

Stem cell status and prognostic applications of cuproptosis-associated lncRNAs in acute myeloid leukemia
by: Zhuodong Chai, et al.
Published: (2025-01-01)

Comprehensive Analysis of Characteristics of Cuproptosis-Related LncRNAs Associated with Prognosis of Lung Adenocarcinoma and Tumor Immune Microenvironment
by: Feihong Chen, et al.
Published: (2024-09-01)

A novel cuproptosis-related lncRNAs signature predicts prognostic and immune of bladder urothelial carcinoma
by: Zheng Zhou, et al.
Published: (2023-03-01)

Cuproptosis-related lncRNAs predict prognosis and immune response of thyroid carcinoma
by: Yinli Shi, et al.
Published: (2023-07-01)

Based on cuproptosis-related lncRNAs, a novel prognostic signature for colon adenocarcinoma prognosis, immunotherapy, and chemotherapy response
by: Chong Li, et al.
Published: (2023-06-01)

Cuproptosis-related lncRNAs potentially predict prognosis and therapy sensitivity of breast cancer
by: Xiwen Wu, et al.
Published: (2023-07-01)

Cuproptosis-related lncRNAs emerge as a novel signature for predicting prognosis in prostate carcinoma and functional experimental validation
by: Yangbai- Lu, et al.
Published: (2024-10-01)

An integrative analysis revealing cuproptosis-related lncRNAs signature as a novel prognostic biomarker in hepatocellular carcinoma
by: Xilang Chen, et al.
Published: (2023-02-01)

Development and validation of cuproptosis-related lncRNAs associated with pancreatic cancer immune microenvironment based on single-cell
by: Yimeng Sun, et al.
Published: (2023-09-01)

Comprehensive analysis of cuproptosis-related lncRNAs in immune infiltration and prognosis in hepatocellular carcinoma
by: Chunhua Liu, et al.
Published: (2023-01-01)

Unravelling the complex interplay of cuproptosis, lncRNAs, and immune infiltration in Alzheimer’s disease: a step towards novel therapeutic targets
by: Yi Zeng, et al.
Published: (2024-12-01)

LncRNAs signatures associated with cuproptosis predict the prognosis of endometrial cancer
by: Shiyuan Qi, et al.
Published: (2023-04-01)

Establishment of a prognostic signature for lung adenocarcinoma using cuproptosis-related lncRNAs
by: Saiyidan Yalimaimaiti, et al.
Published: (2023-03-01)

Prediction of immune infiltration and prognosis for patients with cholangiocarcinoma based on a cuproptosis-related lncRNA signature
by: Hong-Fei Yao, et al.
Published: (2024-01-01)

Cuproptosis-related lncRNA signatures: Predicting prognosis and evaluating the tumor immune microenvironment in lung adenocarcinoma
by: Pengpeng Zhang, et al.
Published: (2023-01-01)

Identification of a novel prognostic cuproptosis-associated LncRNA signature for predicting prognosis and immunotherapy response in patients with esophageal cancer
by: Xinhai Sun, et al.
Published: (2024-05-01)

Construction of a cuproptosis-associated lncRNA prognostic signature for bladder cancer and experimental validation of cuproptosis-related lncRNA UBE2Q1-AS1
by: Junlin Shen, et al.
Published: (2023-08-01)

Cuproptosis related lncRNA signature as a prognostic and therapeutic biomarker in osteosarcoma immunity
by: Ziwei Gao, et al.
Published: (2025-01-01)

Prognostic Significance and Immune Landscape of a Cuproptosis-Related LncRNA Signature in Ovarian Cancer
by: Min Zhou, et al.
Published: (2024-11-01)

Cuproptosis-related lncRNAs predict the clinical outcome and immune characteristics of hepatocellular carcinoma
by: Hongfei Zhu, et al.
Published: (2022-09-01)

A novel cuproptosis-related lncRNA signature predicts the prognosis and immune landscape in bladder cancer
by: Yuchen Bai, et al.
Published: (2022-11-01)

Cuproptosis-related lncRNA signature for prognostic prediction in patients with acute myeloid leukemia
by: Yidong Zhu, et al.
Published: (2023-02-01)

Novel cuproptosis-related long non-coding RNA signature to predict prognosis in prostate carcinoma
by: Xiaofeng Cheng, et al.
Published: (2023-01-01)

Cuproptosis-related LncRNAs are correlated with immunity and predict prognosis in HNSC independent of TMB
by: Mingyu Li, et al.
Published: (2023-02-01)

Cuproptosis-related lncRNA signature as a prognostic tool and therapeutic target in diffuse large B cell lymphoma
by: Xiaoran Bai, et al.
Published: (2024-06-01)

A cuproptosis-related lncRNA signature for predicting prognosis and immune response in hepatocellular carcinoma
by: Jingyi Wu, et al.
Published: (2023-09-01)

Identification of cuproptosis-related lncRNAs signature for predicting the prognosis in patients with kidney renal clear cell carcinoma
by: Ya He, et al.
Published: (2024-03-01)

Prognosis and personalized treatment prediction in lung adenocarcinoma: An in silico and in vitro strategy adopting cuproptosis related lncRNA towards precision oncology
by: Chao Ma, et al.
Published: (2023-02-01)

Cuproptosis-related lncRNA signatures predict prognosis and immune relevance of kidney renal papillary cell carcinoma
by: Tongjin Xie, et al.
Published: (2022-12-01)

Development and validation of ferroptosis-related lncRNAs signature for hepatocellular carcinoma
by: Jiaying Liang, et al.
Published: (2021-06-01)